Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
CLYM | Climb Bio, Inc. | Director | Jun 26, 2024 | |||
FULC | Fulcrum Therapeutics, Inc. | President, Research & Development | Jan 19, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|